Skip to content
2000
Volume 10, Issue 1
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The induction of neoangiogenesis is a critical step already present at the early stages of tumor development and dissemination. The progressive identification of molecules playing a relevant role in neoangiogenesis has fostered the development of a wide variety of new selective agents. Antiangiogenic drugs should be integrated with conventional therapies; however, the design of the best sequence and timing for such combined treatments are still under investigation. In this review will be discussed the signal transduction mechanisms of angiogenic molecules, the development of specific inhibitors and their translation into clinical studies and, finally, the new perspectives in antiangiogenic therapy.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612043453595
2004-01-01
2024-11-21
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612043453595
Loading

  • Article Type:
    Review Article
Keyword(s): Angiogenesis; Antiangiogenic; Cancer Therapy; neoangiogenesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test